Olema Pharmaceuticals Inc (OLMA)
NASDAQ
News
Market Data
Register for streaming realtime charts, analysis tools, and prices.
The current OLMA market cap is 821.67M. The company's latest EPS is USD -1.7280 and P/E is -8.50.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -27.22M | -29.6M | -21.6M | -23.34M | -30.42M |
| Net Income | -26.18M | -28.29M | -20.1M | -21.5M | -26.77M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -4.32M | -21.53M | -71.49M | -106.99M | -104.96M |
| Net Income | -4.32M | -23.99M | -71.1M | -104.79M | -96.66M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 215.65M | 195.77M | 177.62M | 292.8M | 276.95M |
| Total Liabilities | 18.1M | 20.79M | 16.04M | 17.67M | 23.05M |
| Total Equity | 197.55M | 174.98M | 161.58M | 275.13M | 253.9M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 132k | 342.72M | 295.95M | 215.65M | 276.95M |
| Total Liabilities | 1.38M | 4.59M | 11.38M | 18.1M | 23.05M |
| Total Equity | -10.59M | 338.14M | 284.57M | 197.55M | 253.9M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -82.07M | -20.39M | -42.51M | -65.25M | -83.73M |
| Investing | 91.48M | 37.39M | 51.5M | 26.06M | -4.85M |
| Financing | 476k | 220k | 2.26M | 132.89M | 133.42M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -3.08M | -19.87M | -50.69M | -82.07M | -83.73M |
| Investing | N/A | -56k | -275.44M | 91.48M | -4.85M |
| Financing | N/A | 358.4M | 1.39M | 476k | 133.42M |
| Market Cap | 821.67M |
| Price to Earnings Ratio | -8.50 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 11.99 |
| Price to Book Ratio | 3.24 |
| Dividend Yield | - |
| Shares Outstanding | 55.93M |
| Average Volume (1 week) | 526.96k |
| Average Volume (1 Month) | 612.61k |
| 52 Week Change | 62.68% |
| 52 Week High | 17.7911 |
| 52 Week Low | 7.78 |
| Spread (Intraday) | 0.82 (5.53%) |
| Company Name | Olema Pharmaceuticals Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://olema.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
